| Literature DB >> 36211327 |
Naiara Ozamiz-Etxebarria1, Maria Dosil-Santamaria2, Nahia Idoiaga Mondragon1, Maitane Picaza Gorrotxategi3, Beatriz Olaya4,5, Javier Santabárbara4,6,7.
Abstract
Background and objectives: : Since the beginning of the COVID-19 pandemic, the young population has been suffering from an accumulation of psychological symptoms in northern Spain. The main objectives of this study were (1) to assess whether psychological symptoms persisted after one year and a half of the COVID-19 pandemic in northern Spain sample of young people, and (2) to analyze whether pandemic-specific variables (having a chronic illness, living with a person who has a chronic illness, having been infected with COVID-19, having a close person who has died or believing that people are respecting the measures imposed) are related to psychological symptomatology.Entities:
Keywords: COVID-19; anxiety; depression; stress; young people
Year: 2022 PMID: 36211327 PMCID: PMC9527219 DOI: 10.1016/j.ejpsy.2022.09.007
Source DB: PubMed Journal: Eur J Psychiatry ISSN: 0213-6163
Psychological symptomatology scores according to sociodemographic characteristics.
| Female (n=391) | 8.29 | 0.005 | 0.34 | 5.40 | 0.007 | 0.32 | 0.32 | 0.53 | |
| Male (n=85) | 6.49 | 3.94 | 8.71 | ||||||
| 18-25 (n= 385) | 8.08 | 0.46 | 5.20 | 0.70 | 8.96 | 0.42 | |||
| 26-35 (n=94) | 7.63 | 5.00 | 9.40 |
Note.The bold values in the table represent the values reaching statistical significance (p-value <0 .05); d: Cohen's d (Only when significative); SD: Standard deviation. The "non-binary" group has been excluded as they represent only 0.6% of the sample.
Frequencies and percentages of different symptoms shown by youths (mild, moderate, severe, and highly severe) according to pandemic related variables
| No-depression | 29 (40.8%) | 127 (29.5%) | 28 (28%) | 119 (31.3) | 87 (30.7%) | 60 (30.8%) | |
| Mild | 5 (10.2%) | 53 (12.3%) | 11 (11%) | 47 (12.4%) | 32 (11.3%) | 26 (13.3%) | |
| Moderated | 14 (28.6%) | 116 (27% ) | 32 (32%) | 98 (25.9%) | 77 (27.1%) | 53 (27.2%) | |
| Severe | 1 (2%) | 64 (14.9%) | 14 (14% ) | 51 (13.5%) | 41 (14.4%) | 24 (12.3%) | |
| Extremely severe | 9 (18.4%) | 70 (16.3%) | 15 (15% ) | 64 (16.9%) | 47 (16.5%) | 32 (16.4%) | |
| No-anxiety | 22 (44,9%) | 161 (37.4%) | 38 (38%) | 175 (46.2%) | 124 (43.7%) | 89 (45.7%) | |
| Mild | 3 (6.1%) | 43 (10%) | 16 (16% ) | 30 (7.9%)) | 28 (9.9%) | 18 (9.2%) | |
| Moderated | 12 (24.5%) | 96 (22.3%) | 25 (25%) | 83 (21.9%) | 62 (21.8%) | 46 (23.6%) | |
| Severe | 4 (8.2%) | 37 (8.6%) | 6 (6%) | 35 (9.2%) | 25 (8.8%) | 16 (8.2%) | |
| Extremely severe | 8 (16.3%) | 63 (14.7%) | 15 (15%) | 56 (14.8% ) | 45 (15.8%) | 26 (13.3) | |
| No-stress | 18 (36.7%) | 163 (38%) | 43 (43%) | 138 (36.4%) | 102 (35.9%) | 79 (40.5%) | |
| Mild | 14 (28.6%) | 84 (19.5%) | 19 (19%) | 79 (20.8%) | 60 (21.1%) | 38 (19.5%) | |
| Moderated | 4 (8.2% ) | 78 (18.1%) | 15 (15% ) | 67 (17.7%) | 47 (16.5%) | 35 (17.9%) | |
| Severe | 8 (16.3% ) | 71 (16.5% ) | 13 (13% ) | 66 (17.4%) | 49 (17.3%) | 30 (15.4%) | |
| Extremely severe | 5 (10.2%) | 34 (7.9%) | 10 (10% ) | 29 (7.7%) | 26 (9.2%) | 13 (6.7%) | |
Frequencies and percentages of different symptoms shown by youths (mild, moderate, severe, and highly severe) according to pandemic related variables
| No-depression | 13 (28.3%) | 226 (52.19%) | 5(15.6%) | 234 (52.3%) | 72 (29.5%) | 75 (31.9%) | |
| Mild | 9 (19.6%) | 37 (8.5%) | 4 (12.5%) | 42 (9.4% ) | 32 (13.1%) | 26 (11.1%) | |
| Moderated | 11 (23.9%) | 79 (18.2%) | 8 (25%) | 82 (218.3%) | 67 (27.3%) | 63 (26.9%) | |
| Severe | 7 (15.2%) | 39 (19.0%) | 7 (21.9%) | 39 (8.7%) | 33 (13.5%) | 32 (13.7%) | |
| Extremely severe | 6 (13%) | 52 (12.0%) | 8 (25%) | 50 (11.2%) | 40 (16.3%) | 39 (16.7%) | |
| No-anxiety | 19 (41.3%) | 280 (64.7%) | 6 (18.8%) | 293 (65.5%) | 115 (47.13%) | 98 (41.7%) | |
| Mild | 5 (10.9% ) | 28 (6.4%) | 1 (3.1%) | 32 (7.2%) | 25 (10.2%) | 21 (9%) | |
| Moderated | 12 (26.1%) | 61(14.08%) | 11(34.4%) | 62 (13.9%) | 49 (20%) | 59 (25.2) | |
| Severe | 3 (6.5%3) | 21 (4.8%) | 4 (12.5%) | 20 (4.5%) | 21 (8.6%) | 20 (8.5%) | |
| Extremely severe | 7 (15.2%) | 43(9.9%) | 10 (31.3%) | 40 (8.9%) | 34 (13.9%) | 37 (15.8%) | |
| No-stress | 18 (39.2%) | 249 (57.5%) | 4 (12.5%) | 263 (58.8%) | 92 (37.7%) | 89 (37.9%) | |
| Mild | 10 (21.7%) | 62 (14.3%) | 8 (25%) | 64 (14.31%) | 53 (21.6%) | 45 (19.2%) | |
| Moderated | 7 (15.2%) | 50 (11.5% ) | 10 (31.3%) | 47 (10.5%) | 40 (16.3%) | 42 (17.9%) | |
| Severe | 9 (19.6%) | 46 (10.6%) | 9 (28.1%) | 46 (10.39%) | 43 (17.6%) | 36 (15.4%) | |
| Extremely severe | 2 (4.3%) | 26 (6.0% ) | 1 (3.1% 1) | 27 (6.0%) | 16 (6.5%) | 23 (9.8%) | |
Differences in symptomatology (controlling for age) according to COVID-related variables.
| Yes | 7.85 | 4.87 | 85 | -.431 | .667 | 5.19 | 4.57 | 85 | -.032 | .974 | 8.50 | 4.98 | 391 | -.973 | .331 | |||||
| No | 8.14 | 5.58 | 300 | 5.20 | 4.70 | 300 | 9.09 | 4.89 | 85 | |||||||||||
| Yes | 8.93 | 6.01 | 15 | 1.09 | .276 | 7.01 | 5.31 | 15 | 2.11 | .038* | .60 | 9.60 | 4.95 | 15 | .189 | .850 | ||||
| No | 7.37 | 4.84 | 79 | 4.62 | 3.71 | 79 | 9.36 | 4.25 | 79 | |||||||||||
| Yes | 9.56 | 5.39 | 27 | 1.26 | .209 | 7.70 | 5.01 | 27 | 2.94 | .004** | .59 | 10.67 | 4.01 | 27 | 1.91 | .05* | .39 | |||
| No | 8.13 | 5.56 | 247 | 4.87 | 4.71 | 247 | 8.75 | 5.09 | 247 | |||||||||||
| Yes | 8.40 | 4.21 | 5 | .605 | .547 | 7.40 | 6.06 | 5 | 1.60 | .095 | 11.20 | 3.90 | 5 | 1.07 | .208 | |||||
| No | 7.06 | 4.77 | 62 | 4.30 | 3.77 | 62 | 9.06 | 4.31 | 62 | |||||||||||
| Yes | 8.14 | 5.47 | 189 | -.193 | .847 | 4.73 | 4.26 | 189 | 1.94 | .05* | .20 | 8.53 | 4.78 | 189 | 1.48 | .092 | ||||
| No | 8.03 | 5.41 | 196 | 5.65 | 5.01 | 196 | 9.37 | 5.01 | 196 | |||||||||||
| Yes | 7.42 | 5.02 | 56 | .463 | .645 | 4.89 | 3.83 | 56 | .308 | .759 | 10.01 | 4.05 | 56 | -1.68 | .097 | |||||
| No | 7.92 | 5.13 | 38 | 5.15 | 4.45 | 38 | 8.50 | 4.65 | 38 | |||||||||||
***p<0.001; p<0.01**; p<0.05*
Note: SD= Standard Deviation; n= number of participants; d= Cohen's effect size